Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.49 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.49 |
| ▸ | MLNR | O43193 | 1/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.49 |
| ▸ | PGR | P06401 | 1/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.49 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11378629 | 1.00 | ESR1 (0.49) | ESR1ADORA3AGTR1KCNH2MLNR | |
| SCHEMBL11359878 | 1.00 | ESR1 (0.49) | ESR1ADORA3AGTR1KCNH2MLNR | |
| Cetrimonium SCHEMBL11374448 | 1.00 | ESR1 (0.49) | ESR1ADORA3AGTR1KCNH2MLNR | |
| SCHEMBL11368461 | 1.00 | ESR1 (0.49) | ESR1ADORA3AGTR1KCNH2MLNR | |
| SCHEMBL11362584 | 0.93 | ESR1 (0.46) | ESR1ADORA3AGTR1KCNH2MLNR | |
| Phenyl Dihydrogen Phosphate SCHEMBL11362295 | 0.91 | ESR1 (0.49) | ESR1ADORA3AGTR1KCNH2MLNR | |
| Phenyl Dihydrogen Phosphate SCHEMBL11374481 | 0.91 | ESR1 (0.49) | ESR1ADORA3AGTR1KCNH2MLNR | |
| SCHEMBL11364700 | 0.91 | MLNR (0.60) | ESR1ADORA3AGTR1KCNH2MLNR | |
| SCHEMBL11372107 | 0.91 | ESR1 (0.49) | ESR1ADORA3AGTR1KCNH2MLNR | |
| SCHEMBL11370988 | 0.91 | ESR1 (0.49) | ESR1ADORA3AGTR1KCNH2MLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4077860-A | Photopolymerizable composition stabilized with ammonium salts of phosphorus acid and process | STAUFFER CHEMICAL COMPANY (US) | 1978-03-07 | — | — | US | claimed |
| US-20040171867-A1 | Reactive monomer composition modified by a small-amount of lactones, an acrylic polyol resin, a curable resin composition, and a coating composition | OKAZAKI AKIRA (JP) | 2004-09-02 | — | — | US | disclosed |
| US-6767987-B2 | CURABLE RESIN COMPOSITION COMPRISING ACRYLIC POLYOL RESIN INCLUDING HYDROXYALKYL(METH)ACRYLATE COMPOSITION HAVING SMALL AMOUNT OF POLYMERIZED LACTONE MONOMER, AND MELAMINE RESIN | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-07-27 | — | — | US | disclosed |
| US-20030149227-A1 | Lowly lactone-modified reactive monomer composition, acrylic polyol resins produced with the same, curable resin compositions and coating compositions | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-08-07 | — | — | US | disclosed |
| EP-1227113-A1 | LOWLY LACTONE-MODIFIED REACTIVE MONOMER COMPOSITION, ACRYLIC POLYOL RESINS PRODUCED WITH THE SAME, CURABLE RESIN COMPOSITIONS AND COATING COMPOSITIONS | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 2002-07-31 | — | — | EP | disclosed |
| EP-0751196-B1 | Curable resin composition, coating composition and process for forming a cured film | NIPPON PAINT CO LTD (JP) | 2000-01-05 | — | — | EP | disclosed |
| US-5932658-A | CURABLE | NIPPON PAINT CO., LTD. (JP) | 1999-08-03 | — | — | US | disclosed |
| EP-0789064-A2 | Curable resin composition, coating composition and method for forming coated film | Nippon Paint Co., Ltd. (JP) | 1997-08-13 | — | — | EP | disclosed |
| EP-0751196-A2 | Curable resin composition, coating composition and process for forming a cured film | Nippon Paint Co., Ltd. (JP) | 1997-01-02 | — | — | EP | disclosed |
| US-4252662-A | EROSION INHIBITOR | STAUFFER CHEMICAL COMPANY (US) | 1981-02-24 | — | — | US | disclosed |
| US-4077860-A | Photopolymerizable composition stabilized with ammonium salts of phosphorus acid and process | STAUFFER CHEMICAL COMPANY (US) | 1978-03-07 | — | — | US | disclosed |
| US-3956154-A | AIRCRAFT | STAUFFER CHEMICAL COMPANY (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171867-A1 | Reactive monomer composition modified by a small-amount of lactones, an acrylic polyol resin, a curable resin composition, and a coating composition | MSR1, FUT4, MRE11 | ESR1 2135/4885ADORA3 523/4885AGTR1 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.